These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 7982875

  • 1. Extended-release clonidine for sleep disorders.
    Horacek HJ.
    J Am Acad Child Adolesc Psychiatry; 1994 Oct; 33(8):1210. PubMed ID: 7982875
    [No Abstract] [Full Text] [Related]

  • 2. Insomnia, night terror, and depression related to clonidine in attention-deficit/hyperactivity disorder.
    Ghanizadeh A.
    J Clin Psychopharmacol; 2008 Dec; 28(6):725-6. PubMed ID: 19011458
    [No Abstract] [Full Text] [Related]

  • 3. Clonidine for stimulant-related sleep problems.
    Rubinstein S, Silver LB, Licamele WL.
    J Am Acad Child Adolesc Psychiatry; 1994 Feb; 33(2):281-2. PubMed ID: 8150803
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. New additions to the psychopharmacopia: extended release formulations.
    Roman MW.
    Issues Ment Health Nurs; 2011 Feb; 32(11):717-9. PubMed ID: 21992264
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Another long-acting methylphenidate (Metadate CD).
    Med Lett Drugs Ther; 2001 Oct 01; 43(1114):83-4. PubMed ID: 11581582
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Letter to the editor: Comment on 'Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder'.
    Olders H.
    J Pediatr Psychol; 2009 Oct 01; 34(1):108-9; author reply 110-2. PubMed ID: 19136567
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Case study: accidental clonidine patch overdose in attention-deficit/hyperactivity disorder patients.
    Broderick-Cantwell JJ.
    J Am Acad Child Adolesc Psychiatry; 1999 Jan 01; 38(1):95-8. PubMed ID: 9893422
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb 01; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Recent developments in the use of antidepressant and anxiolytic medications.
    Simeon JG, Ferguson HB.
    Psychiatr Clin North Am; 1985 Dec 01; 8(4):893-907. PubMed ID: 2867535
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Concepts in pharmacotherapy of insomnia].
    Jordan W, Hajak G.
    Internist (Berl); 1996 May 01; 37(5):490-9. PubMed ID: 9011548
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.